[Research] ABL Bio (298380) – Mirae Asset Securities | BBB Shuttle Re-rating · IGF1R Competitiveness · ABL001 Data Readout / 2026-03-26
Brokerage : Mirae Asset Securities Analyst : Seungmin Kim Investment Rating : Not Rated Target Price : – Core Momentum : Re-rating of the IGF1R-targeting Grabody-B platform following Denali’s initial BBB shuttle FDA approval, alongside upcoming ABL001 Phase 2/3 trial data readout in April 📊 1. [Valuation & Key Financial Metrics] 🚀 2. [Market Opportunities…